An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn’s Disease

INTRODUCTION: Real-world treatment persistence to ustekinumab for Crohn’s disease (CD) was studied using Australian Pharmaceutical Benefits Scheme (PBS) data. Demographic and treatment pattern characteristics were also investigated. METHODS: Our retrospective cohort analysis included PBS 10% sample...

詳細記述

保存先:
書誌詳細
出版年:Biologics
主要な著者: Chien, Tzu Hsiang, Puig, Andrea, Khuong, Thang, Kouhkamari, Mahsa H, Che, Samuel, Huang, Tom Hsun-Wei
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2021
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215905/
https://ncbi.nlm.nih.gov/pubmed/34163137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S310076
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料